(PharmaNewsWire.Com, February 26, 2018 ) The Human Immunodeficiency Virus (HIV) is a retrovirus that assaults the immune system of people and weakens the body toward infections. It attacks and destroys the T-helper cells, a sort of white blood cells, which replicates and produces multiple copies of it inside the white blood cells. T-helper cells also are called CD4 cells. Regularly the immune system becomes prone and at risk of any sort of infections. This situation is called acquired immuno deficiency syndrome (AIDS).
In 2015, 1.1 million people died of HIV associated infections in the Middle East and Africa, and approximately 36.7 million humans struggling with HIV. As a result, the Middle East and Africa HIV Diagnostics market is hastily increasing, ready to offer proper diagnostics by following proper remedy methods.
The Middle East and Africa HIV Diagnostics market was worth USD 195.64 million in 2016 and predicted to be growing at a CAGR of 7.82%, to reach 285.17 million by the end of 2021.
HIV spreads through trade of fluids with a few inflamed hosts, as an instance, blood alternate or offering needles to any individual who is HIV contaminated. Moreover, HIV can unfold from infected mother to child during pregnancy. The symptoms of HIV sickness are a slight fever, weak spot, swollen glands, cerebral pains and muscle aches.
Growing prevalence of HIV has caused problems for the authorities to often put money into activities geared toward curbing sickness burden cases of HIV/AIDS. Multinational fitness care establishments consisting of UNITAID promote attention and resource in finding novel strategies for analysis and eradication of HIV infection. Federal initiative through the authorities of Canada for remedy of HIV/AIDS at different ranges of progression of this sickness is predicted to drive utilization of HIV diagnostic checks.
The Middle East and Africa HIV Diagnostics market hold the overall market proportion of over 38% globally. Africa is expected to develop at a fast tempo in the coming few years, because of increasing spread of HIV across the region. Some of the leading companies dominating the market include Abbott Healthcare, Brsitol-Myers Squibb, Abbvie Inc., Alere Inc., Gilead Sciences, Merck & Co. Inc, Janssen Therapeutics, BD Biosciences, VIIV Healthcare, Partec, Sysmex, Beckman Coulter, Apogee Flow Systems, Zyomyx Inc., PointCare Technologies Inc., Mylan inc., Qiagen, Roche Diagnostics, Siemens Healthcare, and bioMerieux.
Scope of the report The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
